• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 13-11-2025: Press Release

    13-11-2025 | 11:53 am

    Alembic Pharma secured USFDA final approval for Dexlansoprazole (30mg, 60mg) capsules. This drug targets a US market estimated at ~₹2,365 Cr (US$285M), boosting future revenue prospects.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited